C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/08/2001	US20010039666 Non-human mammalian model for atherosclerosis and methods for screening agents for use in the treatment of atherosclerosis
11/08/2001	US20010039480 Apparatus and method for automated protein design
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039334 Hybrids
11/08/2001	US20010039331 16836, a novel human phospholipase C family member and uses thereof
11/08/2001	US20010039263 For binding telomerase; antitumor agents
11/08/2001	US20010039261 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/08/2001	US20010039052 Surface antigen expression allows for identification and selection of genetically modified cells; gene therapy
11/08/2001	US20010039048 Recombinant adenovirus and its use for the prevention and treatment of fibrotic disease
11/08/2001	US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy
11/08/2001	US20010039044 Transfecting cells with a recombinant adeno-associated virus (AAV) which can be package into infectious AAV virions, a helper AAV vector essential for replication and packaging and a productive vector which cannot be packaged into the virion
11/08/2001	US20010039042 Plant biotin synthase
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010039037 Novel polypeptide
11/08/2001	US20010039036 Cloning and recombinant production of receptor(s) of the activin/TGF-beta superfamily
11/08/2001	US20010039034 Method for labeling individual cells
11/08/2001	US20010039026 Assay method
11/08/2001	US20010039021 Polyketides
11/08/2001	US20010039018 Immobilization of unmodified biopolymers to acyl fluoride activated substrates
11/08/2001	US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001	US20010039016 Measurement, calibration gene expression
11/08/2001	US20010039014 Integrated systems and methods for diversity generation and screening
11/08/2001	US20010039013 Screening, diagnosis cancer
11/08/2001	US20010039008 Immunofluorescence
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001	EP1144429A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001	DE10021832A1 Neue für das cma-Gen kodierende Nukleotidsequenzen New coding for the cma gene nucleotide sequences
11/08/2001	DE10021831A1 Neue für das fadD15-Gen kodierende Nukleotidsequenzen New coding for the fadD15 gene nucleotide sequences
11/08/2001	DE10021829A1 Neue für das pgsA2-Gen kodierende Nukleotidsequenzen New coding for the pgsA2 gene nucleotide sequences
11/08/2001	DE10021828A1 Neue für das cdsA-Gen kodierende Nukleotidsequenzen New coding for the CDSA gene nucleotide sequences
11/08/2001	DE10021826A1 New mutant coryneform bacterium, useful for production of amino acids, especially glutamate, has increased activity of cardiolipin synthase
11/08/2001	DE10021667A1 New nucleic acid sequences from Actinoplanes, useful for synthesis and bioconversion of acarbose and related inhibitors of alpha-glucosidase
11/08/2001	DE10021475A1 New opioid-type receptor-1 gene, OTR1, useful for diagnosis and treatment of OTR1-related diseases
11/08/2001	DE10020704A1 Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren Biochip for archiving medical and laboratory analysis of biological sample material, process for its preparation and its use in diagnostic methods
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2712368A1 Dna transfection system for the generation of infectious influenza virus
11/08/2001	CA2414775A1 A method and device for improving protein stability and solubility
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2413265A1 Porcine adenovirus type 5 vector and vaccine
11/08/2001	CA2409686A1 Serine-threonine kinase
11/08/2001	CA2409219A1 Cellular regulators of infectious agents and methods of use
11/08/2001	CA2408254A1 Phytase polypeptides
11/08/2001	CA2408105A1 Novel proteases
11/08/2001	CA2408094A1 Colloid compositions for solid phase biomolecular analytical, preparative and identification systems
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2408003A1 Gamma secretase substrates and in vitro assays
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407942A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
11/08/2001	CA2407900A1 Methods and compositions for effecting homologous recombination
11/08/2001	CA2407893A1 New gtpase-activating protein 1
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407881A1 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	CA2407834A1 Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor crf 2-alpha
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001	CA2407709A1 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407695A1 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407601A1 Novel human phospholipase c delta 5
11/08/2001	CA2407595A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	CA2407460A1 Targeted modification of chromatin structure
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407396A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots
11/08/2001	CA2407303A1 Improved immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/08/2001	CA2407226A1 Polynucleotide probes for detection and quantitation of candida species
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2406743A1 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	CA2406621A1 Protein variants having modified immunogenicity
11/08/2001	CA2405952A1 Novel assay for nucleic acid analysis
11/08/2001	CA2405363A1 Epitope synchronization in antigen presenting cells
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2395101A1 Polynucleotide separations on polymeric separation media
11/08/2001	CA2377877A1 Immunoglobulin bonding protein arrays in plant cells
11/08/2001	CA2324982A1 Method for examining disease
11/07/2001	EP1152370A2 Control of nucleic acid amplification procedures including the polymerase chain reaction (PCR)
11/07/2001	EP1152062A2 High temperature reverse transcription using mutant DNA polymerases
11/07/2001	EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152059A1 Novel cytokine recfptor-like protein
11/07/2001	EP1152058A1 Methods and compositions for effecting homologous recombination
11/07/2001	EP1152057A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof
11/07/2001	EP1152056A1 Method for modifying genetic characteristics of an organism
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152054A1 Novel carbonyl reductase, gene thereof and method of using the same
11/07/2001	EP1152009A1 Novel nucleosides and oligonucleotide analogues
11/07/2001	EP1152008A2 Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid
11/07/2001	EP1151794A2 Underdrain for filtration membrane
11/07/2001	EP1151409A1 Methods of populating data stuctures for use in evolutionary simulations
11/07/2001	EP1151306A1 High throughput mass spectrometry

1 ... 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 ... 4023